BGI China - 2 views
-
tommyru on 25 Feb 22AUSTIN, Texas and SHENZHEN, China, June 24, 2021 /PRNewswire/ - Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, and BGI Genomics Co., Ltd., (300676.SZ), one of the world's leading genomics companies, today announced the launch of the BGI/Natera Signatera Assay which is now available to biopharmaceutical customers and clinicians across China.